Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine

Clinical Transplantation

Volumn 20, Issue 1, 2006, Pages 10-18

  Pelletier, Ronald P ^a,c   Akin, Baris ^b   Ferguson, Ronald M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^c NONE   (United States)

Author keywords

Corticosteroids; Kidney outcomes; Kidney transplant; Patient outcomes

Indexed keywords

BASILIXIMAB; CHOLESTEROL; CYCLOSPORIN A; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL ANTIDIABETIC AGENT; PREDNISONE; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT DISORDER; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIABETES MELLITUS; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STEROID THERAPY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; CREATININE; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; PROSPECTIVE STUDIES; PROTEINURIA;

EID: 33644804177     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00430.x     Document Type: Article

References (38)

1. Khwaja K, Asolati M, Harmon J et al. Outcome at 3 years with a prednisone-free maintenance regimen: A single centre experience with 349 kidney transplant recipients. Am J Transplant 2004: 4: 980.
2. Birkeland SA. Steroid-free immunosuppression in renal transplantation: A long-term follow-up of 100 consecutive patients. Transplantation 2001: 71: 1089.
3. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multi centre randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003: 3: 306.
4. Cole E, Landsberg D, Russell D et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001: 72: 845.
5. Sarwal MM, Yorgin PD, Alexander S et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13.
6. Boots J, Christiaans M, Van Dujnhoven E, Van Suylen R, Van Hooff J. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study. Transplantation 2002: 74: 1703.
7. Leventhal J, Kaufman D, Gallon L et al. Four year single centre experience with prednisone free immunosuppression in 434 kidney transplant recipients. Am J Transplant 2003: 3: 439.
8. Citterio F. Steroid side effects and their impact on transplantation outcome. Transplantation-Supplement 2001: 72: SS75.
9. Prasad G, Nash M, McFarlane P, Zaltzman J. Renal transplant recipient attitude toward steroid use and steroid withdrawal. Clin Transplant 2003: 17: 135.
10. Maes B, Claes K, Coosemans W et al. Cessation of steroids in stable renal transplant patients: The leuven experience. Clin Transpl 2002: 181.
11. Smak Gregoor P, de Sevaux R, Ligtenberg G et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicentre study. J Am Soc Nephrol 2002: 13: 1365.
12. Ahsan N, Hricik D, Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-A prospective randomized study. Transplantation 1999: 68: 1865.
13. Hricik D, Seliga R, Fleming-Brooks S, Bartucci M, Schulak J. Determinants of long term allograft function following steroid withdrawal in renal transplant recipients. Clin Transplant 1995: 9: 419.
14. Hollander AAMJ, Hene RJ, Hermans J, Van Es LA, Van Der Woude FJ. Late prednisone withdrawal in cyclosporine treated kidney transplant patients: A randomized study. J Am Soc Nephrol 1997: 8(2): 294.
15. Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H. Double bind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000: 70: 1352.
16. Ratcliffe P, Dudley C, Higgins R, Firth J, Smith B, Morris P. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. The Lancet 1996: 348: 643.
17. Van den Ham E, Kooman J, Christiaans M, Van Hoof J. The influence of early steroid withdrawal in body composition and bone mineral density in renal transplantation patients. Transplantation International 2003: 16: 82.
18. Budde K, Hallebach G, Beibler S et al. Successful steroid withdrawal at the end of the 1st year after renal transplantation in mycophenolate mofetil-treated patients. Transplant Proc 2002: 34: 1700.
19. Budde K, Geissler S, Hallebach G et al. Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long term cyclosporine treated patients: 4 year follow up. Transplant Proc 2002: 34: 1703.
20. Sinclair N. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992: 147: 645.
21. Dunn T, Asolati M, Holman D et al. Long term outcome of a prospective trial of steroid withdrawal after kidney transplantation. Surgery 1999: 125: 155.
22. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001: 37: 1162.
23. Hilbrands L, Hoitsma A, Koene R. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation. Transplantation 1996: 61: 1038.
24. McKenna RM, Takemoto SK, Terasak PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000: 69 (3): 319.
25. Kupin W, Venkat K, Goggins V et al. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant patients. Transplant Proceedings 1999: 31: 1131.
26. Pichlmayr R, Grinyo J, Groth C, Sadek SA, Vanrenterghem Y. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321.
27. Keown P, Hayry P, Mathew T et al. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029.
28. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995: 60: 225.
29. Vanrenterghem Y. Mycophenolate mofetil in renal transplantation: 3 year results from the placebo-controlled trial. Transplantation 1999: 68: 391.
30. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
31. Moreno A, Torregrosa J, Pons F, Campistol J, Martinez de Osaba M, Oppenheimer F. Bone mineral density after renal transplantation long term follow up. Transplant Proc 1999: 31: 2322.
32. Durieux S, Mercadal L, Orcel PDH et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002: 74: 496.
33. Maiorca R, Cristinelli L, Brunori G et al. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Transplant Proceedings 1988: 20 (Suppl. 3): 121.
34. Puigi-Mari J. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: Results of the Spanish group. Transplant Proc 1999: 31: 2256.
35. Hricik DE, Bartucci MR, Mayes JT, Schular JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992: 54: 868.
36. Grinyo J, Gil-Vernet S, Seron D et al. Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients. Transplantation 1997: 63: 1688.
37. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrom J, Fauchald P. Tapering off prednisone and cyclosporine the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001: 16: 829.
38. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Effects of steroid withdrawal on post transplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991: 51: 374.